We could also be further exploring adeno associated virus (AAV) delivery CAPN5 scFv as a treatment strategy for CAPN5 mutations-linked ADNIV in eye and activated CAPN5 related-neurodegenerative diseases in central nerve system. This evidence concerns the gene CAPN5 and CAPN5-related vitreoretinopathy.